Celecoxib API refers to the products needed to produce celecoxib. It is a first-generation specific COX-2 inhibitor, an anti-arthritis drug, and has little gastrointestinal side effects. It is used to treat arthritis and osteoarthritis.
The global Celecoxib API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Celecoxib API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Celecoxib API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Celecoxib API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Celecoxib API include Pfizer, Punjab Chemicals & Crop Protection, Aurobindo Pharma, Teva Pharmaceuticals, Mylan, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang Pharmaceutical, ScinoPharm and Jiangxi Synergy Pharmaceutical, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Celecoxib API production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Celecoxib API by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Celecoxib API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Celecoxib API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Celecoxib API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Celecoxib API sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Celecoxib API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Celecoxib API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Punjab Chemicals & Crop Protection, Aurobindo Pharma, Teva Pharmaceuticals, Mylan, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang Pharmaceutical, ScinoPharm and Jiangxi Synergy Pharmaceutical, etc.
By Company
Pfizer
Punjab Chemicals & Crop Protection
Aurobindo Pharma
Teva Pharmaceuticals
Mylan
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang Pharmaceutical
ScinoPharm
Jiangxi Synergy Pharmaceutical
Hisun Pharmaceutical Nantong
Segment by Type
0.97
0.99
Others
Segment by Application
Pharmaceutical Industrial
Laboratory
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Celecoxib API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Celecoxib API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Celecoxib API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Celecoxib API Product Introduction
1.2 Market by Type
1.2.1 Global Celecoxib API Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 0.97
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Celecoxib API Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Industrial
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Celecoxib API Production
2.1 Global Celecoxib API Production Capacity (2018-2029)
2.2 Global Celecoxib API Production by Region: 2018 VS 2022 VS 2029
2.3 Global Celecoxib API Production by Region
2.3.1 Global Celecoxib API Historic Production by Region (2018-2023)
2.3.2 Global Celecoxib API Forecasted Production by Region (2024-2029)
2.3.3 Global Celecoxib API Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Celecoxib API Revenue Estimates and Forecasts 2018-2029
3.2 Global Celecoxib API Revenue by Region
3.2.1 Global Celecoxib API Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Celecoxib API Revenue by Region (2018-2023)
3.2.3 Global Celecoxib API Revenue by Region (2024-2029)
3.2.4 Global Celecoxib API Revenue Market Share by Region (2018-2029)
3.3 Global Celecoxib API Sales Estimates and Forecasts 2018-2029
3.4 Global Celecoxib API Sales by Region
3.4.1 Global Celecoxib API Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Celecoxib API Sales by Region (2018-2023)
3.4.3 Global Celecoxib API Sales by Region (2024-2029)
3.4.4 Global Celecoxib API Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Celecoxib API Sales by Manufacturers
4.1.1 Global Celecoxib API Sales by Manufacturers (2018-2023)
4.1.2 Global Celecoxib API Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Celecoxib API in 2022
4.2 Global Celecoxib API Revenue by Manufacturers
4.2.1 Global Celecoxib API Revenue by Manufacturers (2018-2023)
4.2.2 Global Celecoxib API Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Celecoxib API Revenue in 2022
4.3 Global Celecoxib API Sales Price by Manufacturers
4.4 Global Key Players of Celecoxib API, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Celecoxib API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Celecoxib API, Product Offered and Application
4.8 Global Key Manufacturers of Celecoxib API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Celecoxib API Sales by Type
5.1.1 Global Celecoxib API Historical Sales by Type (2018-2023)
5.1.2 Global Celecoxib API Forecasted Sales by Type (2024-2029)
5.1.3 Global Celecoxib API Sales Market Share by Type (2018-2029)
5.2 Global Celecoxib API Revenue by Type
5.2.1 Global Celecoxib API Historical Revenue by Type (2018-2023)
5.2.2 Global Celecoxib API Forecasted Revenue by Type (2024-2029)
5.2.3 Global Celecoxib API Revenue Market Share by Type (2018-2029)
5.3 Global Celecoxib API Price by Type
5.3.1 Global Celecoxib API Price by Type (2018-2023)
5.3.2 Global Celecoxib API Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Celecoxib API Sales by Application
6.1.1 Global Celecoxib API Historical Sales by Application (2018-2023)
6.1.2 Global Celecoxib API Forecasted Sales by Application (2024-2029)
6.1.3 Global Celecoxib API Sales Market Share by Application (2018-2029)
6.2 Global Celecoxib API Revenue by Application
6.2.1 Global Celecoxib API Historical Revenue by Application (2018-2023)
6.2.2 Global Celecoxib API Forecasted Revenue by Application (2024-2029)
6.2.3 Global Celecoxib API Revenue Market Share by Application (2018-2029)
6.3 Global Celecoxib API Price by Application
6.3.1 Global Celecoxib API Price by Application (2018-2023)
6.3.2 Global Celecoxib API Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Celecoxib API Market Size by Type
7.1.1 US & Canada Celecoxib API Sales by Type (2018-2029)
7.1.2 US & Canada Celecoxib API Revenue by Type (2018-2029)
7.2 US & Canada Celecoxib API Market Size by Application
7.2.1 US & Canada Celecoxib API Sales by Application (2018-2029)
7.2.2 US & Canada Celecoxib API Revenue by Application (2018-2029)
7.3 US & Canada Celecoxib API Sales by Country
7.3.1 US & Canada Celecoxib API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Celecoxib API Sales by Country (2018-2029)
7.3.3 US & Canada Celecoxib API Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Celecoxib API Market Size by Type
8.1.1 Europe Celecoxib API Sales by Type (2018-2029)
8.1.2 Europe Celecoxib API Revenue by Type (2018-2029)
8.2 Europe Celecoxib API Market Size by Application
8.2.1 Europe Celecoxib API Sales by Application (2018-2029)
8.2.2 Europe Celecoxib API Revenue by Application (2018-2029)
8.3 Europe Celecoxib API Sales by Country
8.3.1 Europe Celecoxib API Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Celecoxib API Sales by Country (2018-2029)
8.3.3 Europe Celecoxib API Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Celecoxib API Market Size by Type
9.1.1 China Celecoxib API Sales by Type (2018-2029)
9.1.2 China Celecoxib API Revenue by Type (2018-2029)
9.2 China Celecoxib API Market Size by Application
9.2.1 China Celecoxib API Sales by Application (2018-2029)
9.2.2 China Celecoxib API Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Celecoxib API Market Size by Type
10.1.1 Asia Celecoxib API Sales by Type (2018-2029)
10.1.2 Asia Celecoxib API Revenue by Type (2018-2029)
10.2 Asia Celecoxib API Market Size by Application
10.2.1 Asia Celecoxib API Sales by Application (2018-2029)
10.2.2 Asia Celecoxib API Revenue by Application (2018-2029)
10.3 Asia Celecoxib API Sales by Region
10.3.1 Asia Celecoxib API Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Celecoxib API Revenue by Region (2018-2029)
10.3.3 Asia Celecoxib API Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Celecoxib API Market Size by Type
11.1.1 Middle East, Africa and Latin America Celecoxib API Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Celecoxib API Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Celecoxib API Market Size by Application
11.2.1 Middle East, Africa and Latin America Celecoxib API Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Celecoxib API Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Celecoxib API Sales by Country
11.3.1 Middle East, Africa and Latin America Celecoxib API Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Celecoxib API Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Celecoxib API Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Overview
12.1.3 Pfizer Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Pfizer Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer Recent Developments
12.2 Punjab Chemicals & Crop Protection
12.2.1 Punjab Chemicals & Crop Protection Company Information
12.2.2 Punjab Chemicals & Crop Protection Overview
12.2.3 Punjab Chemicals & Crop Protection Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Punjab Chemicals & Crop Protection Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Punjab Chemicals & Crop Protection Recent Developments
12.3 Aurobindo Pharma
12.3.1 Aurobindo Pharma Company Information
12.3.2 Aurobindo Pharma Overview
12.3.3 Aurobindo Pharma Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Aurobindo Pharma Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Aurobindo Pharma Recent Developments
12.4 Teva Pharmaceuticals
12.4.1 Teva Pharmaceuticals Company Information
12.4.2 Teva Pharmaceuticals Overview
12.4.3 Teva Pharmaceuticals Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Teva Pharmaceuticals Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Teva Pharmaceuticals Recent Developments
12.5 Mylan
12.5.1 Mylan Company Information
12.5.2 Mylan Overview
12.5.3 Mylan Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Mylan Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mylan Recent Developments
12.6 Jiangsu Hengrui Medicine
12.6.1 Jiangsu Hengrui Medicine Company Information
12.6.2 Jiangsu Hengrui Medicine Overview
12.6.3 Jiangsu Hengrui Medicine Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Jiangsu Hengrui Medicine Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Jiangsu Hengrui Medicine Recent Developments
12.7 Jiangsu Chiatai Qingjiang Pharmaceutical
12.7.1 Jiangsu Chiatai Qingjiang Pharmaceutical Company Information
12.7.2 Jiangsu Chiatai Qingjiang Pharmaceutical Overview
12.7.3 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Jiangsu Chiatai Qingjiang Pharmaceutical Recent Developments
12.8 ScinoPharm
12.8.1 ScinoPharm Company Information
12.8.2 ScinoPharm Overview
12.8.3 ScinoPharm Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 ScinoPharm Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 ScinoPharm Recent Developments
12.9 Jiangxi Synergy Pharmaceutical
12.9.1 Jiangxi Synergy Pharmaceutical Company Information
12.9.2 Jiangxi Synergy Pharmaceutical Overview
12.9.3 Jiangxi Synergy Pharmaceutical Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Jiangxi Synergy Pharmaceutical Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Jiangxi Synergy Pharmaceutical Recent Developments
12.10 Hisun Pharmaceutical Nantong
12.10.1 Hisun Pharmaceutical Nantong Company Information
12.10.2 Hisun Pharmaceutical Nantong Overview
12.10.3 Hisun Pharmaceutical Nantong Celecoxib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Hisun Pharmaceutical Nantong Celecoxib API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hisun Pharmaceutical Nantong Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Celecoxib API Industry Chain Analysis
13.2 Celecoxib API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Celecoxib API Production Mode & Process
13.4 Celecoxib API Sales and Marketing
13.4.1 Celecoxib API Sales Channels
13.4.2 Celecoxib API Distributors
13.5 Celecoxib API Customers
14 Celecoxib API Market Dynamics
14.1 Celecoxib API Industry Trends
14.2 Celecoxib API Market Drivers
14.3 Celecoxib API Market Challenges
14.4 Celecoxib API Market Restraints
15 Key Finding in The Global Celecoxib API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Pfizer
Punjab Chemicals & Crop Protection
Aurobindo Pharma
Teva Pharmaceuticals
Mylan
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang Pharmaceutical
ScinoPharm
Jiangxi Synergy Pharmaceutical
Hisun Pharmaceutical Nantong
*If Applicable.